0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

NEW ANTIHYPERTENSION DRUGS

Henry A. Schroeder, M.D.
JAMA. 1952;149(3):297. doi:10.1001/jama.1952.02930200083023.
Text Size: A A A
Published online

ABSTRACT

To the Editor:—  Recent announcements in the press of a method to control hypertension by the use of hexamethonium chloride and hydrazinophthalazine have inspired considerable confusion and conflicting comments in both lay and medical circles. Some tabloid newspapers gave a distorted, overenthusiastic view, other papers were reasonably factual, but several reprinted follow-up stories inspired by another investigator branding the method as "dangerous." In addition, literature mailed to physicians by the manufacturer of a preparation of hexamethonium chloride contained erroneous statements attributed to me. Since the truth lies between these conflicting statements, I am attempting to clarify the confusion.A method for the partial temporary control of arterial hypertension has been developed, a preliminary report of which was published in the A. M. A. Archives of Internal Medicine (89:523 [April] 1952). This method has been extended to include approximately 120 patients suffering from arterial hypertension of all degrees of severity,

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();